Democratic members of the House aren’t messing around.
Last week, the House Ways and Means Committee held its first hearing on Social Security expansion for the first time in nearly 50 years. And today, the very same committee will discuss the skyrocketing cost of prescription drugs.
But it’s not just talk. This month, Reps. Lloyd Doggett (D-TX), Peter Welch (D-VT) and Elijah Cummings (D-MD) introduced The Medicare Negotiation and Competitive Licensing Act. This bill would finally allow Medicare to negotiate drug prices―harnessing the government’s purchasing power and restraining Big Pharma’s monopoly pricing.
Become a grassroots co-signer of the new Medicare Negotiation and Competitive Licensing Act and demand Congress act to rein in skyrocketing prescription drug prices.
Americans pay the highest price in the world for prescription drugs―over 40% more than Canada and often three times that of many European countries.
In 2015, the five largest drug corporations raked in more than $50 billion in profits. At the same time, 35 million people, nearly 20% of the U.S. population, did not fill a prescription because they could not afford it.
Each year, out-of-pocket health care costs eat up more than half of every annual Social Security benefit. Even with critical programs such as Medicare and Social Security, many seniors cannot afford the skyrocketing price of their medications.
In order to counter the greedy pharmaceutical corporations―that are spending millions of dollars on an army of Washington lobbyists―we need your help.
The pharmaceutical industry won’t give up its grip on its record profits without a fight. And this bill is a crucial tool to fight back.
CONTRIBUTOR
Comments